Palatin Technologies Announced Database Lock For Its PL9643 Melody-1 Phase 3 Trial Evaluating The Safety And Efficacy Of PL9643 Versus Vehicle For Dry Eye Disease; Top-line Results Expected In February
Author: Benzinga Newsdesk | February 05, 2024 08:32am